Doctors test cord blood cells as potential new treatment for aggressive MS
NCT ID NCT04943289
Summary
This early-stage study tested whether injecting specialized cells from donated umbilical cord blood into the spinal fluid is safe for adults with primary progressive multiple sclerosis (PPMS). Twenty participants received a single injection of these cells and were monitored for one year to check for side effects. Researchers also looked for early signs that the treatment might help slow disease progression or improve symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
Conditions
Explore the condition pages connected to this study.